A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus

NCT00882726 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

133

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: CNTO 3649 IV (Healthy participants)
DRUG: CNTO 3649 SC (Healthy participants)
DRUG: CNTO 3649 SC (Diabetic patients)
DRUG: Placebo

Sponsor

Centocor, Inc.